IV Hydration Therapy Market Size, Shares and Trends 2025 - 2035
According to Payal Rabde, who specializes in intravenous administration of fluids, electrolytes, vitamins, minerals, and medications, to restore hydration and support overall health, rapid rehydration, nutrient delivery, recovery support, and management of dehydration-related conditions, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the IV hydration market. The global IV hydration therapy market size was estimated at USD 4.82 billion in 2025 and is predicted to increase from USD 5.56 billion in 2026 to approximately USD 19.96 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035. Her analysis highlights the increasing adoption of wellness-focused IV infusion therapies, increasing use of IV hydration for rapid fluid and nutrient replenishment, growing demand for preventive health and recovery treatments, expanding adoption of mobile and outpatient infusion services, and increasing preference for personalized intravenous nutrient therapy. The research also examines the competitive strategies of key industry participants, including, Baxter Internationa Inc. B Barun SE, Otsuka Pharmaceutical Co. Ltd, Grisfols, S.A., JW Life Science Corporation, Amanta Healthcare, and REVIV Global, shaping the future by expanding personalized infusion therapies based on individual health needs, integrating digital health platforms with infusion services management, enabling at-home IV therapy through portable infusion technologies, advancing precision nutrition and customized hydration solutions, and leveraging remote patient monitoring to improve infusion therapy outcomes in the global IV hydration therapy market.
Last Updated : 01 July 2026
Category: Therapeutic Area
Insight Code: 6984
Format: PDF / PPT / Excel